Cough and viruses in airways disease: Mechanisms

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 2, 2009, Pages 108-113

  Footitt, Joseph ^a   Johnston, Sebastian L ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Acute cough; Cough; Respiratory virus infection

Indexed keywords

ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; BROMPHENIRAMINE; IPRATROPIUM BROMIDE; LEUKOTRIENE; NAPROXEN; NEUROPEPTIDE; PSEUDOEPHEDRINE; RIBAVIRIN; RUPINTRIVIR; TIOTROPIUM BROMIDE;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COUGHING; DISEASE MODEL; HUMAN; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; SYMPTOM; VIRAL RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ANIMALS; ASTHMA; COMMON COLD; COUGH; DISEASE SUSCEPTIBILITY; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT INFECTIONS; RHINOVIRUS;

EID: 61649084651     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.12.022     Document Type: Article

References (57)

1. Morice A.H. Epidemiology of cough. Pulmonary Pharmacol Ther 15 3 (2002) 253-259
2. Gonzales R., Malone D.C., Maselli J.H., and Sande M.A. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 33 6 (2001) 757-762
3. Fendrick A.M., Monto A.S., Nightengale B., and Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 163 4 (2003) 487-494
4. Jones B.F., and Stewart M.A. Duration of cough in acute upper respiratory tract infections. Aust Fam Physician 31 10 (2002) 971-973
5. Regamey N. Viral etiology of acute respiratory infections with cough in infancy: a community-based birth cohort study. Pediatric Infect Dis J 27 2 (2008) 100
6. Decalmer S.C., Webster D., Kelsall A., McGuinness K., Woodcock A., and Smith A.J. Chronic cough: how do cough reflex sensitivity and subjective assessments correlate with objective cough counts during ambulatory monitoring?. Thorax 62 4 (2007) 329-334
7. Kelsall A., Decalmer S.C., McGuinness K., Woodcock A., and Smith J.A. Sex differences and predictors of objective cough frequency in chronic cough. Thorax (2009) 10.1136/thx.2008.106237
8. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310 6989 (1995) 1225-1229
9. Corne J.M., Marshall C., Smith S., Schreiber J., Sanderson G., Holgate S.T., et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359 9309 (2002) 831-834
10. Inoue D., Yamaya M., Kubo H., Sasaki T., Hosoda M., Numasaki M., et al. Mechanisms of mucin production by rhinovirus infection in cultured human airway epithelial cells. Respir Physiol Neurobiol 154 3 (2006) 484-499
11. Papadopoulos N.G., Stanciu L.A., Papi A., Holgate S.T., and Johnston S.L. A defective type 1 response to rhinovirus in atopic asthma. Thorax 57 4 (2002) 328-332
12. Message S.D., Laza-Stanca V., Mallia P., Parker H.L., Zhu J., Kebadze T., et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A 105 36 (2008) 13562-13567
13. Contoli M., Message S.D., Laza-Stanca V., Edwards M.R., Wark P.A., Bartlett N.W., et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 12 9 (2006) 1023-1026
14. Papi A., Bellettato C.M., Braccioni F., Romagnoli M., Casolari P., Caramori G., et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173 10 (2006) 1114-1121
15. Rohde G., Wiethege A., Borg I., Kauth M., Bauer T.T., Gillissen A., et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58 1 (2003) 37-42
16. Seemungal T., Harper-Owen R., Bhowmik A., Moric I., Sanderson G., Message S., et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 9 (2001) 1618-1623
17. Johnston N.W. The similarities and differences of epidemic cycles of chronic obstructive pulmonary disease and asthma exacerbations. Proc Am Thorac Soc 4 8 (2007) 591-596
18. Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet 371(9621):1364-1374.
19. Jacoby D.B. Virus-induced asthma attacks. JAMA 287 6 (2002) 755-761
20. Mamessier E., Nieves A., Lorec A.M., Dupuy P., Pinot D., Pinet C., et al. T-cell activation during exacerbations:a longitudinal study in refractory asthma. Allergy 63 9 (2008) 1202
21. Tripp R.A., Moore D., Winter J., and Anderson L.J. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J Virol 74 4 (2000) 1614-1622
22. Tripp R.A., Barskey A., Goss L., and Anderson L.J. Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection. J Neuroimmunol 129 1-2 (2002) 141-153
23. Dakhama A., Park J.-W., Taube C., El Gazzar M., Kodama T., Miyahara N., et al. Alteration of airway neuropeptide expression and development of airway hyperresponsiveness following respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 288 4 (2005) L761-L770
24. Dakhama A., Kanehiro A., Makela M.J., Loader J.E., Larsen G.L., and Gelfand E.W. Regulation of airway hyperresponsiveness by calcitonin gene-related peptide in allergen sensitized and challenged mice. Am J Respir Crit Care Med 165 8 (2002) 1137-1144
25. Carr M.J., Hunter D.D., Jacoby D.B., and Undem B.J. Expression of tachykinins in nonnociceptive vagal afferent neurons during respiratory viral infection in guinea pigs. Am J Respir Crit Care Med 165 8 (2002) 1071-1075
26. Dusser D.J., Jacoby D.B., Djokic T.D., Rubinstein I., Borson D.B., and Nadel J.A. Virus induces airway hyperresponsiveness to tachykinins: role of neutral endopeptidase. J Appl Physiol 67 4 (1989) 1504-1511
27. Piedimonte G., Hegele R.G., and Auais A. Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats. Pediatric Res 55 4 (2004) 657-665
28. Kohrogi H., Graf P.D., Sekizawa K., Borson D.B., and Nadel J.A. Neutral endopeptidase inhibitors potentiate substance P- and capsaicin-induced cough in awake guinea pigs. J Clin Invest 82 6 (1988) 2063-2068
29. Hu C., Wedde-Beer K., Auais A., Rodriguez M.M., and Piedimonte G. Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am J Physiol Lung Cell Mol Physiol 283 2 (2002) L494-L502
30. Fryer A.D., and Jacoby D.B. Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 102 (1991) 267-271
31. Jacoby D.B., Xiao H.Q., Lee N.H., Chan-Li Y., and Fryer A.D. Virus- and interferon-induced loss of inhibitory M2 muscarinic receptor function and gene expression in cultured airway parasympathetic neurons. J Clin Invest 102 1 (1998) 242-248
32. Cui Y.-Y., Zhu L., Wang H., Advenier C., Chen H.-Z., and Devillier P. Muscarinic receptors involved in airway vascular leakage induced by experimental gastro-oesophageal reflux. Life Sci 82 17-18 (2008) 949-955
33. Picado C. Mechanisms of aspirin sensitivity. Curr Allergy Asthma Rep 6 3 (2006) 198-202
34. Arakida Y., Ohga K., Okada Y., Morio H., Suwa K., Yokota M., et al. Effect of combined leukotriene D4 and thromboxane A2 receptor antagonist on mediator-controlled resistance in guinea pigs. Eur J Pharmacol 403 1-2 (2000) 169-179
35. Bisgaard H. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 167 3 (2003) 379-383
36. Seymour M.L., Gilby N., Bardin P.G., Fraenkel D.J., Sanderson G., Penrose J.F., et al. Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis 185 4 (2002) 540-544
37. Hewson C.A., Edbrooke M.R., and Johnston S.L. PMA Induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-[alpha], Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J Mol Biol 344 3 (2004) 683-695
38. Makela M.J., Puhakka T., Ruuskanen O., Leinonen M., Saikku P., Kimpimaki M., et al. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 36 2 (1998) 539-542
39. Bartlett N.W., Walton R.P., Edwards M.R., Aniscenko J., Caramori G., Zhu J., et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat Med 14 (2008) 199-204
40. Bardin P.G., Sanderson G., Robinson B.S., Holgate S.T., and Tyrrell D.A. Experimental rhinovirus infection in volunteers. Eur Respir J 9 11 (1996) 2250-2255
41. Fraenkel D.J., Bardin P.G., Sanderson G., Lampe F., Johnston S.L., and Holgate S.T. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 151 3 (1995) 879-886
42. Mallia P., Message S., Kebadze T., Parker H., Kon O., and Johnston S. An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations:a pilot study. Respir Res 7 1 (2006) 116
43. Smith J.A., Owen E.C., Jones A.M., Dodd M.E., Webb A.K., and Woodcock A. Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis. Thorax 61 5 (2006) 425-429
44. Smith J., Owen E., Earis J., and Woodcock A. Cough in COPD: correlation of objective monitoring with cough challenge and subjective assessments. Chest 130 2 (2006) 379-385
45. Barry S., Dane A., Morice A., and Walmsley A. The automatic recognition and counting of cough. Cough 2 1 (2006) 8
46. Matos S., Birring S.S., Pavord I.D., and Evans H. Detection of cough signals in continuous audio recordings using hidden Markov models. IEEE Trans Biomed Eng 53 6 (2006) 1078-1083
47. Dicpinigaitis P., Spinner L., Santhyadka G., and Negassa A. Effect of tiotropium on cough reflex sensitivity in acute viral cough. Lung 186 6 (2008) 369-374
48. Hayden F.G., Diamond L., Wood P.B., Korts D.C., and Wecker M.T. Effectiveness and safety of intranasal ipratropium bromide in common colds: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 125 2 (1996) 89-97
49. Curley F.J., Irwin R.S., Pratter M.R., Stivers D.H., Doern G.V., Vernaglia P.A., et al. Cough and the common cold. Am Rev Respir Dis 138 2 (1988) 305-311
50. Berkowitz R.B., Connell J.T., Dietz A.J., Greenstein S.M., and Tinkelman D.G. The effectiveness of the nonsedating antihistamine loratadine plus pseudoephedrine in the symptomatic management of the common cold. Ann Allergy 63 4 (1989) 336-339
51. Sperber S.J., Hendley J.O., Hayden F.G., Riker D.K., Sorrentino J.V., and Gwaltney J.M. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial. Ann Intern Med 117 1 (1992) 37-41
52. Hayden F.G., Turner R.B., Gwaltney J.M., Chi-Burris K., Gersten M., Hsyu P., et al. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother 47 12 (2003) 3907-3916
53. Patick A.K. Rhinovirus chemotherapy. Antiviral Res 71 2-3 (2006) 391-396
54. Barry W., Cockburn F., Cornall R., Price J.F., Sutherland G., and Vardag A. Ribavirin aerosol for acute bronchiolitis. Arch Dis Child 61 6 (1986) 593-597
55. Randolph A.G., and Wang E.E. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract. Cochrane Database Syst Rev 2 (2000) CD000181
56. Smyth RL, Openshaw PJM. Bronchiolitis. Lancet 368(9532):312-322.
57. Lee P.C.L., Jawad M.S.M., and Eccles R. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 52 (2000) 1137-1142